• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手握力作为失代偿期肝硬化男性患者肌少症筛查工具。

Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis.

机构信息

Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh 160 012, India.

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160 012, India.

出版信息

Indian J Gastroenterol. 2022 Jun;41(3):284-291. doi: 10.1007/s12664-022-01255-2. Epub 2022 Jul 19.

DOI:10.1007/s12664-022-01255-2
PMID:35852763
Abstract

BACKGROUND

Skeletal muscle index (SMI), the gold standard for sarcopenia, cannot measure muscle strength and requires specialized software and training. Hand-grip strength (HGS) measurement is cheap, requires minimal training and directly reflects muscle strength. We assessed the performance of HGS as a screening tool for sarcopenia in male patients with decompensated cirrhosis (DC).

METHODS

Consecutive male DC patients (n=155) were enrolled. Baseline liver functions, etiologic work-up and anthropometric measurements were done. SMI was determined from computed tomography (CT) images at L3 level using ImageJ software. Sarcopenia was diagnosed using SMI cut-off <42 cm/m as suggested by the Indian National Association for Study of the Liver. HGS was assessed using a hand-grip dynamometer. Diagnostic performance of HGS for discriminating sarcopenia was described using receiver operating characteristic (ROC) analysis. Diagnostic performance of different HGS cut-offs was assessed. Findings were internally validated using bootstrapping.

RESULTS

Mean HGS and SMI were 25.73 ± 5.94 kg and 47.72 ± 8.71 cm/m, respectively. HGS showed modest correlation with SMI (tau: 0.31, p <0.001). Sarcopenia was seen in 41 (26.5%) patients. Age and HGS were independent predictors of sarcopenia on multivariate analysis. Area under the ROC curve (AUROC) of HGS for detecting sarcopenia was 0.73 (p<0.001). Optimal cut-off for using HGS as a screening tool was ≤31 kg (sensitivity: 37/41 [90.2%]; specificity: 29/114 [25.4%]; positive predictive value [PPV] : 37/122 [30.3%]; and negative predictive value [NPV]: 29/33 [87.9%]).

CONCLUSION

Prevalence of sarcopenia in Indian male patients with DC is 26.5%. HGS is an independent predictor of sarcopenia and can be used as a screening tool to stratify the need for confirmatory CT-based assessment of sarcopenia.

摘要

背景

骨骼肌指数(SMI)是肌少症的金标准,但无法衡量肌肉力量,且需要专门的软件和培训。手握力(HGS)测量价格便宜,所需培训最少,且直接反映肌肉力量。我们评估了 HGS 作为男性失代偿期肝硬化(DC)患者肌少症筛查工具的性能。

方法

连续纳入男性 DC 患者(n=155)。进行基线肝功能、病因学检查和人体测量学测量。使用 ImageJ 软件从 L3 水平的 CT 图像确定 SMI。根据印度国家肝病研究协会建议的 SMI 截断值<42 cm/m 诊断肌少症。使用握力计评估 HGS。使用受试者工作特征(ROC)分析描述 HGS 区分肌少症的诊断性能。评估了不同 HGS 截断值的诊断性能。使用自举法对内部分验证结果。

结果

平均 HGS 和 SMI 分别为 25.73 ± 5.94 kg 和 47.72 ± 8.71 cm/m。HGS 与 SMI 呈中度相关(tau:0.31,p<0.001)。41 例(26.5%)患者存在肌少症。年龄和 HGS 是多变量分析中肌少症的独立预测因素。HGS 检测肌少症的 ROC 曲线下面积(AUROC)为 0.73(p<0.001)。使用 HGS 作为筛查工具的最佳截断值为≤31 kg(灵敏度:41/41 [90.2%];特异性:114/29 [25.4%];阳性预测值[PPV]:122/41 [30.3%];阴性预测值[NPV]:33/29 [87.9%])。

结论

印度男性 DC 患者肌少症的患病率为 26.5%。HGS 是肌少症的独立预测因素,可作为一种筛查工具,用于分层确定是否需要进行基于 CT 的肌少症确认性评估。

相似文献

1
Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis.手握力作为失代偿期肝硬化男性患者肌少症筛查工具。
Indian J Gastroenterol. 2022 Jun;41(3):284-291. doi: 10.1007/s12664-022-01255-2. Epub 2022 Jul 19.
2
Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis.简单的床边肌肉力量和功能测试与计算机断层扫描骨骼肌指数相关,可用于评估肝硬化患者的肌肉减少症。
Indian J Gastroenterol. 2023 Jun;42(3):379-387. doi: 10.1007/s12664-023-01338-8. Epub 2023 May 24.
3
Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients.握力(HGS)和生物电阻抗分析(BIA)在诊断肝硬化患者肌少症中的应用。
BMC Gastroenterol. 2022 Mar 30;22(1):159. doi: 10.1186/s12876-022-02236-7.
4
Normative cutoffs of muscle mass, muscle strength, and frailty for healthy Indian population.健康印度人群肌肉量、肌肉力量和虚弱的规范界值。
Indian J Gastroenterol. 2022 Dec;41(6):591-598. doi: 10.1007/s12664-022-01295-8. Epub 2023 Jan 5.
5
European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.欧洲老年人肌少症工作组(EWGSOP2)标准结合基于人群的骨骼肌指数最能预测亚洲肝硬化患者的死亡率。
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):52-60. doi: 10.1016/j.jceh.2021.03.015. Epub 2021 Apr 8.
6
Prevalence of Sarcopenia and Relationships Between Muscle and Bone in Indian Men and Women.肌肉减少症在印度男女中的流行情况以及肌肉与骨骼之间的关系。
Calcif Tissue Int. 2021 Oct;109(4):423-433. doi: 10.1007/s00223-021-00860-1. Epub 2021 May 9.
7
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy.化疗期消化系统癌症患者肌肉质量与握力的相关性。
Cancer Med. 2019 Jul;8(8):3677-3684. doi: 10.1002/cam4.2238. Epub 2019 May 21.
8
Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.相位角作为结直肠癌患者肌肉异常和功能的标志物。
Clin Nutr. 2021 Jul;40(7):4799-4806. doi: 10.1016/j.clnu.2021.06.013. Epub 2021 Jun 17.
9
Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.使用胸部计算机断层扫描 (CT) 影像在第一腰椎 (L1) 水平评估骨骼肌量的可行性:一项回顾性研究。
PeerJ. 2023 Dec 11;11:e16652. doi: 10.7717/peerj.16652. eCollection 2023.
10
Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.肝硬化中的肌肉减少症:与双能X线吸收法和人体测量法相比,计算机断层扫描在评估肌肉量方面的作用。
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):328-34. doi: 10.1097/MEG.0000000000000274.

引用本文的文献

1
Sarcopenia and Pleural Mesothelioma: The Current Knowledge.肌肉减少症与胸膜间皮瘤:当前认知
Muscles. 2024 Feb 8;3(1):48-59. doi: 10.3390/muscles3010006.
2
Skeletal Muscle Mass Index and Body Fat Percentage Reflect Different Nutritional Markers Independent of BMI in Underweight Women.骨骼肌质量指数和体脂百分比反映了体重过轻女性中与体重指数无关的不同营养指标。
Nutrients. 2025 May 23;17(11):1766. doi: 10.3390/nu17111766.
3
Comparing the performance of 3 sarcopenia definitions for predicting adverse events prior to liver transplant.

本文引用的文献

1
Standardization of grip strength measurements. Effects on repeatability and peak force.握力测量的标准化。对重复性和峰值力的影响。
Scand J Rehabil Med. 1991;23(4):203-6.
比较3种肌肉减少症定义在预测肝移植前不良事件方面的表现。
Hepatol Commun. 2025 May 29;9(6). doi: 10.1097/HC9.0000000000000701. eCollection 2025 Jun 1.
4
Sarcopenia and Frailty in Cirrhotic Patients: Evaluation of Prevalence and Risk Factors in a Single-Centre Cohort Study.肝硬化患者的肌肉减少症和衰弱:单中心队列研究中患病率及危险因素的评估
Medicina (Kaunas). 2025 Apr 29;61(5):821. doi: 10.3390/medicina61050821.
5
Hepatic cirrhosis and decompensation: Key indicators for predicting mortality risk.肝硬化及其失代偿:预测死亡风险的关键指标。
World J Hepatol. 2025 Mar 27;17(3):104580. doi: 10.4254/wjh.v17.i3.104580.
6
Cutoff points for handgrip strength in patients with liver cirrhosis: a multicenter study.肝硬化患者握力的截断点:一项多中心研究。
Eur J Clin Nutr. 2025 May;79(5):484-489. doi: 10.1038/s41430-024-01563-0. Epub 2025 Jan 14.
7
Sarcopenia diagnosis using skeleton-based gait sequence and foot-pressure image datasets.基于骨骼的步态序列和足底压力图像数据集进行肌肉减少症诊断。
Front Public Health. 2024 Nov 27;12:1443188. doi: 10.3389/fpubh.2024.1443188. eCollection 2024.
8
Sarcopenia as a Preoperative Risk Stratification Tool among Older Adults with Inflammatory Bowel Disease.肌少症作为老年炎症性肠病患者术前风险分层工具
Adv Geriatr Med Res. 2024;6(2). doi: 10.20900/agmr20240003. Epub 2024 May 30.
9
Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.肝硬化性肌少症:探讨其流行情况及与肝病严重程度和并发症的关系。
Indian J Gastroenterol. 2024 Aug;43(4):813-820. doi: 10.1007/s12664-024-01550-0. Epub 2024 Jun 7.
10
SARC-F Score: A Quick Bedside Tool to Screen Sarcopenia in Patients With Cirrhosis.SARC-F评分:一种用于筛查肝硬化患者肌肉减少症的快速床边工具。
J Clin Exp Hepatol. 2024 May-Jun;14(3):101318. doi: 10.1016/j.jceh.2023.101318. Epub 2023 Dec 13.